.jpg)
.png)
JK is a 35-year-old female nonsmoker who first presented to clinical lipidology care after developing angina while breastfeeding her first child. A subsequent cardiac catheterization revealed 3-vessel disease, ultimately leading to coronary artery bypass grafting (CABG). Her low-density lipoprotein cholesterol (LDL-C) was 419 mg/dL. Her father has hypercholesterolemia and underwent CABG before age 40, after his first myocardial infarction.
Article By:
Associate Professor of Clinical Medicine
University of Pennsylvania
Philadelphia, PA
Diplomate, American Board of Clinical Lipidology
Penn Medicine: The Heart Group of Lancaster General Health
Lancaster, PA
Diplomate, Accreditation Council of Clinical Lipidology
Assistant Professor of Clinical Medicine
University of Pennsylvania
Philadelphia, PA
Case History
Article By:
Preventive Cardiology and Risk Factor Management
Cardiovascular Medical Associates, PC
Philadelphia, PA
Diplomate, Accreditation Council of Clinical Lipidology
Up to 80 percent of post-menopausal women suffer from a variety of symptoms related to decreased estrogen. The most common symptoms are vasomotor symptoms (VMS) such as hot flashes and night sweats. Painful intercourse, vaginal dryness, and urinary incontinence are considered vulvovaginal atrophy or part of the genitourinary syndrome of menopause (GSM).
Article By:
PharmD candidate class of 2018
Western New England University
Springfield, MA
Pharmacy Resident
Stratton VA Medical Center
Albany, NY
Clinical Pharmacy Specialist
Stratton VA Medical Center
Albany, NY
Assistant Clinical Professor at Albany Medical Center
OB/GYN Lead Physician & Director of Women’s Health
Stratton VA Medical Center
Albany, NY
Hormone replacement therapy (HRT) in post-menopausal women has been a topic of constant debate.
Article By:
VA Western New York Health Care System
Buffalo, NY
VA Western New York Health Care System
Buffalo, NY
VA Western New York Health Care System
Buffalo, NY
President, Northeast Lipid Association
Clinical Pharmacy Coordinator
VA Western NY Healthcare System
Clinical Instructor of Pharmacy
State University of New York at Buffalo
Buffalo, NY
Diplomate, Accreditation Council of Clinical Lipidology
Evidence in support of statins for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) in women was sparse until recently.1 However, meta-analyses have documented that statins significantly reduce ASCVD event rates in women with elevated baseline risk.2,3,4
Article By:
Director, Lipid Clinic and Cardiovascular Disease Prevention Program
Lifespan Cardiovascular Institute
East Greenwich, RI
Diplomate, American Board of Clinical Lipidology
The 2013 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults suggest that there are four adult-treatment groups for whom moderate or high-intensity statin drugs should be prescribed, including adults with:
Article By:
Instructor in Medicine
Harvard Medical School
Director
LDL Apheresis Unit
Massachusetts General Hospital
Boston, MA
Diplomate, American Board of Clinical Lipidology
A 52-year-old woman was referred to our Lipid Clinic several weeks ago by her primary care physician who felt overwhelmed and exasperated and was asking for assistance in her management.
Article By:
Medical Director Lipid Clinic and Physician Advisor for Chronic Disease Management
Ascension Wisconsin All Saints
Racine, WI
Diplomate, American Board of Clinical Lipidology
I am proud to represent the Northeast Lipid Association (NELA) as president, and in my 30th year of clinical lipidology. At the start of my practice at the the VA Medical Center (VAMC), lovastatin and ATP-1 were just introduced. In these 30 years of practice LDL-C targets have changed from 130mg/dL to less than 70mg/dL.
Article By:
Clinical Pharmacy Coordinator
VA Western NY Healthcare System
Clinical Instructor of Pharmacy
State University of New York at Buffalo
Buffalo, NY
Diplomate, Accreditation Council of Clinical Lipidology
Great organizations thrive by looking forward, and the National Lipid Association is no different.
In looking forward, we must have a vision of how we will continue to grow our brand and membership, which ultimately helps advance the practice of clinical lipidology. NLA leadership, along with some special invited guests, met in Orlando for a Strategic Planning session in January to define exactly what that vision looks like.
Article By:
President, National Lipid Association
Clinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for
Prevention of Cardiovascular Disease
Director, Bellevue Hospital Lipid Clinic New York, NY
Diplomate, American Board of Clinical Lipidology
JACKSONVILLE, Fla. -- The National Lipid Association announced Monday it has united with MD Magazine®, a leading online and print source of physician news, conference coverage, and peer-to-peer discussion, through Michael J. Hennessy Associates' Strategic Alliance Partnership (SAP) Program. The partnership will also include sister publications, Rare Disease Report® and Pharmacy Times®.